Regents of the University of California’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Regents of the University of California’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-198,310	Closed	-$234K	–	34
2022 Q4	$234K	Hold	198,310	–	–	0.04%	30
2022 Q3	$460K	Buy	+198,310	New	+$519K	0.09%	30

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $448M AUM 6.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Regents of the University of California's GRNA Position: Q1 2023 in Review

Regents of the University of California sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2023, closing a stake of 198,310 shares — an estimated $234K sold.

Regents of the University of California first reported a position in GRNA in Q3 2022 and held it in 2 quarters. The position peaked at $460K in Q3 2022. 60 funds tracked by Wall St. Rank hold GRNA as of Q1 2023.

Regents of the University of California reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2023 after selling out during the quarter.
Regents of the University of California sold 198,310 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2023, an estimated $234K.
Regents of the University of California first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2022 and held it in 2 quarters.
Regents of the University of California's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $460K in Q3 2022.
60 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2023.

Based on Regents of the University of California's 13F filing for Q1 2023, filed 5 May 2023.